Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$476.16
6.281.34%
al cierre: -
$476.16
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Intuitive Surgical Inc ha un obiettivo di prezzo di consenso pari a $526.72, stabilito in base alle ultime valutazioni degli analisti di 26. Le ultime 3 valutazioni degli analisti sono state rilasciate da RBC Capital, UBS y Piper Sandler il agosto 19, 2025, julio 23, 2025 y julio 23, 2025. Con un obiettivo di prezzo medio di $598.33 tra le RBC Capital, UBS y Piper Sandler, c'è un implicito 25.66% upside per Intuitive Surgical Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
RBC Capital
UBS
Piper Sandler
Truist Securities
Wells Fargo
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Intuitive Surgical
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/19/2025 | 29.16% | RBC Capital | $615 → $615 | Reiterates | Outperform → Outperform | |||
07/23/2025 | 22.86% | UBS | $547 → $585 | Maintains | Neutral | |||
07/23/2025 | 24.96% | Piper Sandler | $575 → $595 | Reiterates | Overweight → Overweight | |||
07/23/2025 | 26.01% | Truist Securities | $590 → $600 | Maintains | Buy | |||
07/23/2025 | 29.16% | RBC Capital | $605 → $615 | Maintains | Outperform | |||
07/23/2025 | 25.8% | Wells Fargo | $559 → $599 | Maintains | Overweight | |||
07/23/2025 | 19.92% | BTIG | $566 → $571 | Maintains | Buy | |||
07/08/2025 | 15.51% | Evercore ISI Group | $470 → $550 | Maintains | In-Line | |||
06/09/2025 | -7.59% | Deutsche Bank | $515 → $440 | Downgrade | Hold → Sell | |||
05/22/2025 | 36.51% | Citigroup | $590 → $650 | Maintains | Buy | |||
04/24/2025 | 33.36% | Barclays | $684 → $635 | Maintains | Overweight | |||
04/23/2025 | 27.06% | RBC Capital | $630 → $605 | Maintains | Outperform | |||
04/23/2025 | 23.91% | Truist Securities | $605 → $590 | Maintains | Buy | |||
04/23/2025 | 20.76% | Piper Sandler | $670 → $575 | Maintains | Overweight | |||
04/23/2025 | -1.29% | Evercore ISI Group | $510 → $470 | Maintains | In-Line | |||
04/23/2025 | 20.76% | Baird | $600 → $575 | Maintains | Outperform | |||
03/18/2025 | 26.01% | Baird | $707 → $600 | Maintains | Outperform | |||
03/17/2025 | 27.06% | Truist Securities | $666 → $605 | Maintains | Buy | |||
01/24/2025 | 22.86% | Deutsche Bank | $505 → $585 | Maintains | Hold | |||
01/24/2025 | 39.87% | Truist Securities | $640 → $666 | Maintains | Buy | |||
01/24/2025 | 44.49% | Raymond James | $560 → $688 | Maintains | Outperform | |||
01/24/2025 | 40.71% | Piper Sandler | $538 → $670 | Reiterates | Overweight → Overweight | |||
01/24/2025 | 44.28% | Wells Fargo | $630 → $687 | Maintains | Overweight | |||
01/24/2025 | 49.32% | Citigroup | $640 → $711 | Maintains | Buy | |||
01/24/2025 | 41.76% | JP Morgan | $575 → $675 | Maintains | Overweight | |||
12/18/2024 | 34.41% | Truist Securities | $570 → $640 | Maintains | Buy | |||
12/11/2024 | 34.41% | Citigroup | $567 → $640 | Maintains | Buy | |||
12/11/2024 | 32.31% | Wells Fargo | $549 → $630 | Maintains | Overweight | |||
12/05/2024 | 28.11% | Stifel | $525 → $610 | Maintains | Buy | |||
12/02/2024 | 36.51% | Morgan Stanley | $522 → $650 | Upgrade | Equal-Weight → Overweight | |||
11/26/2024 | 17.82% | BTIG | $535 → $561 | Maintains | Buy | |||
11/19/2024 | — | Erste Group | — | Upgrade | Hold → Buy | |||
10/18/2024 | 2.91% | Evercore ISI Group | $475 → $490 | Maintains | In-Line | |||
10/18/2024 | 12.36% | BTIG | $518 → $535 | Maintains | Buy | |||
10/18/2024 | 12.99% | Piper Sandler | $495 → $538 | Reiterates | Overweight → Overweight | |||
10/18/2024 | 10.26% | Stifel | $475 → $525 | Maintains | Buy | |||
10/18/2024 | 15.3% | Wells Fargo | $466 → $549 | Maintains | Overweight | |||
10/18/2024 | 16.56% | RBC Capital | $525 → $555 | Maintains | Outperform | |||
10/18/2024 | 18.66% | Baird | $503 → $565 | Maintains | Outperform | |||
10/14/2024 | 13.41% | Raymond James | $500 → $540 | Maintains | Outperform | |||
10/14/2024 | 8.79% | BTIG | $494 → $518 | Maintains | Buy | |||
10/14/2024 | 19.71% | Truist Securities | $520 → $570 | Maintains | Buy | |||
10/11/2024 | 20.76% | JP Morgan | $495 → $575 | Maintains | Overweight | |||
10/08/2024 | 10.26% | RBC Capital | $515 → $525 | Maintains | Outperform | |||
10/01/2024 | -0.24% | Evercore ISI Group | $410 → $475 | Maintains | In-Line | |||
08/28/2024 | 3.75% | BTIG | $469 → $494 | Maintains | Buy | |||
08/22/2024 | 17.61% | Citigroup | $512 → $560 | Maintains | Buy | |||
08/02/2024 | 7.11% | Redburn Atlantic | $380 → $510 | Upgrade | Neutral → Buy | |||
07/23/2024 | 7.11% | Barclays | $490 → $510 | Maintains | Overweight | |||
07/19/2024 | 3.96% | JP Morgan | $475 → $495 | Maintains | Overweight | |||
07/19/2024 | -0.24% | Morgan Stanley | $460 → $475 | Maintains | Equal-Weight | |||
07/19/2024 | 9.21% | Truist Securities | $515 → $520 | Maintains | Buy | |||
07/19/2024 | -1.5% | BTIG | $459 → $469 | Maintains | Buy | |||
07/19/2024 | -13.89% | Evercore ISI Group | $425 → $410 | Maintains | In-Line | |||
07/19/2024 | -0.24% | Stifel | $430 → $475 | Maintains | Buy | |||
07/19/2024 | 3.96% | Piper Sandler | $490 → $495 | Maintains | Overweight | |||
07/19/2024 | 5.64% | Baird | $487 → $503 | Maintains | Outperform | |||
07/18/2024 | 2.91% | Barclays | $430 → $490 | Maintains | Overweight | |||
07/16/2024 | 8.16% | Truist Securities | $450 → $515 | Maintains | Buy | |||
07/15/2024 | -3.6% | BTIG | $451 → $459 | Maintains | Buy | |||
07/15/2024 | -3.39% | Morgan Stanley | $375 → $460 | Maintains | Equal-Weight | |||
07/10/2024 | 7.53% | Citigroup | $462 → $512 | Maintains | Buy | |||
07/09/2024 | 2.91% | Piper Sandler | $435 → $490 | Maintains | Overweight | |||
07/02/2024 | -10.74% | Evercore ISI Group | $385 → $425 | Maintains | In-Line | |||
05/30/2024 | 5.01% | Goldman Sachs | → $500 | Initiates | → Buy | |||
04/19/2024 | -11.58% | BTIG | $412 → $421 | Maintains | Buy | |||
04/19/2024 | -8.64% | Piper Sandler | $425 → $435 | Maintains | Overweight | |||
04/19/2024 | -21.24% | Jefferies | $365 → $375 | Maintains | Hold | |||
04/19/2024 | -8.43% | Baird | $440 → $436 | Maintains | Outperform | |||
04/08/2024 | -9.69% | Stifel | $420 → $430 | Maintains | Buy | |||
04/03/2024 | -2.97% | Citigroup | $428 → $462 | Maintains | Buy | |||
03/15/2024 | -11.79% | Stifel | → $420 | Reiterates | Buy → Buy | |||
01/25/2024 | -18.09% | Mizuho | $350 → $390 | Maintains | Neutral | |||
01/25/2024 | -9.69% | Barclays | $385 → $430 | Maintains | Overweight | |||
01/25/2024 | -8.64% | Raymond James | $372 → $435 | Maintains | Outperform | |||
01/24/2024 | -9.27% | RBC Capital | $400 → $432 | Maintains | Outperform | |||
01/24/2024 | -11.79% | Stifel | $360 → $420 | Maintains | Buy | |||
01/24/2024 | -8.64% | Truist Securities | $390 → $435 | Maintains | Buy | |||
01/24/2024 | -10.74% | Piper Sandler | $325 → $425 | Maintains | Overweight | |||
01/19/2024 | -12.63% | Wells Fargo | $363 → $416 | Maintains | Overweight | |||
01/12/2024 | -15.99% | RBC Capital | $380 → $400 | Maintains | Outperform | |||
01/03/2024 | -21.88% | Raymond James | $310 → $372 | Maintains | Outperform | |||
12/22/2023 | -18.09% | Truist Securities | $375 → $390 | Maintains | Buy | |||
12/12/2023 | -21.24% | Truist Securities | $320 → $375 | Maintains | Buy | |||
12/04/2023 | -30.7% | Morgan Stanley | $300 → $330 | Maintains | Equal-Weight | |||
11/17/2023 | -26.5% | Stifel | $315 → $350 | Maintains | Buy | |||
11/17/2023 | -33.22% | HSBC | → $318 | Initiates | → Buy | |||
10/23/2023 | -37% | Morgan Stanley | $330 → $300 | Maintains | Equal-Weight | |||
10/20/2023 | -31.75% | Piper Sandler | $385 → $325 | Maintains | Overweight | |||
10/20/2023 | -25.45% | RBC Capital | → $355 | Reiterates | Outperform → Outperform | |||
10/20/2023 | -18.09% | Citigroup | $400 → $390 | Maintains | Buy | |||
10/20/2023 | -23.77% | Wells Fargo | $386 → $363 | Maintains | Overweight | |||
10/20/2023 | -34.9% | Raymond James | $368 → $310 | Maintains | Outperform | |||
10/16/2023 | -28.18% | Leerink Partners | → $342 | Initiates | → Outperform | |||
08/17/2023 | -24.4% | RBC Capital | → $360 | Reiterates | Outperform → Outperform | |||
07/24/2023 | -30.7% | Morgan Stanley | $310 → $330 | Maintains | Equal-Weight | |||
07/24/2023 | -19.14% | Barclays | $314 → $385 | Maintains | Overweight | |||
07/24/2023 | -22.72% | Raymond James | $323 → $368 | Maintains | Outperform | |||
07/21/2023 | -23.35% | JP Morgan | $335 → $365 | Maintains | Overweight | |||
07/21/2023 | -19.14% | Piper Sandler | $315 → $385 | Maintains | Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Intuitive Surgical (ISRG)?
El último precio objetivo de Intuitive Surgical (NASDAQ:ISRG) fue comunicado por RBC Capital el agosto 19, 2025. La firma de analistas fijó un precio objetivo para $615.00 que espera ISRG a rise dentro de 12 meses (un posible 29.16% upside). 46 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Intuitive Surgical (ISRG)?
La última calificación de analistas para Intuitive Surgical (NASDAQ:ISRG) fue proporcionada por RBC Capital, y Intuitive Surgical reiterado su outperform calificación.
¿Cuándo se produjo la última revisión al alza de Intuitive Surgical (ISRG)?
La última revisión al alza de Intuitive Surgical Inc se produjo en diciembre 2, 2024, cuando Morgan Stanley elevó su precio objetivo a $650. Morgan Stanley anteriormente tenía an equal-weight para Intuitive Surgical Inc.
¿Cuándo fue la última revisión a la baja de Intuitive Surgical (ISRG)?
La última revisión a la baja de Intuitive Surgical Inc se produjo en junio 9, 2025, cuando Deutsche Bank cambió su precio objetivo de $515 a $440 para Intuitive Surgical Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Intuitive Surgical (ISRG)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Intuitive Surgical, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Intuitive Surgical se registró el agosto 19, 2025, por lo que la próxima calificación estará disponible en torno al agosto 19, 2026.
¿Es correcta la calificación de los analistas sobre Intuitive Surgical (ISRG)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Intuitive Surgical (ISRG) fue un reiterado con un precio objetivo de $615.00 a $615.00. El precio actual al que cotiza Intuitive Surgical (ISRG) es de $476.16, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.